Acadia Healthcare Company, Inc. (NASDAQ:ACHC) had its target price lifted by stock analysts at Deutsche Bank AG from $58.00 to $60.00 in a report released on Monday, July 31st. The firm currently has a “buy” rating on the stock. Deutsche Bank AG’s price target would indicate a potential upside of 27.93% from the company’s previous close.
A number of other brokerages have also weighed in on ACHC. Zacks Investment Research lowered Acadia Healthcare from a “hold” rating to a “sell” rating in a report on Thursday, April 6th. Cantor Fitzgerald reaffirmed a “hold” rating and issued a $45.00 target price on shares of Acadia Healthcare in a research report on Wednesday, April 26th. Jefferies Group LLC reiterated a “buy” rating on shares of Acadia Healthcare in a research note on Friday, May 5th. Leerink Swann cut Acadia Healthcare from an “outperform” rating to a “market perform” rating in a research note on Monday, May 15th. Finally, KeyCorp reiterated an “overweight” rating and issued a $51.00 price objective on shares of Acadia Healthcare in a research note on Thursday, June 1st. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the stock. Acadia Healthcare currently has a consensus rating of “Buy” and a consensus price target of $59.21.
Shares of Acadia Healthcare (NASDAQ ACHC) traded down 0.19% on Monday, reaching $46.90. 2,127,576 shares of the company were exchanged. The firm has a 50 day moving average price of $50.51 and a 200-day moving average price of $45.06. Acadia Healthcare has a 12-month low of $32.54 and a 12-month high of $54.34. The stock has a market capitalization of $4.12 billion, a PE ratio of 515.38 and a beta of 1.15.
Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings data on Thursday, July 27th. The company reported $0.66 EPS for the quarter, topping analysts’ consensus estimates of $0.65 by $0.01. Acadia Healthcare had a net margin of 0.30% and a return on equity of 8.69%. The business had revenue of $715.90 million for the quarter, compared to analysts’ expectations of $717.38 million. During the same quarter last year, the company earned $0.73 EPS. The business’s revenue was down 5.4% on a year-over-year basis. On average, analysts predict that Acadia Healthcare will post $2.45 EPS for the current fiscal year.
COPYRIGHT VIOLATION WARNING: “Deutsche Bank AG Increases Acadia Healthcare Company, Inc. (ACHC) Price Target to $60.00” was posted by BNB Daily and is the property of of BNB Daily. If you are reading this news story on another website, it was copied illegally and republished in violation of U.S. and international trademark & copyright legislation. The legal version of this news story can be read at https://www.baseball-news-blog.com/2017/08/19/deutsche-bank-ag-increases-acadia-healthcare-company-inc-achc-price-target-to-60-00-updated-updated.html.
In other Acadia Healthcare news, Director William Grieco sold 2,000 shares of the business’s stock in a transaction dated Friday, June 16th. The stock was sold at an average price of $45.42, for a total value of $90,840.00. Following the completion of the sale, the director now owns 47,013 shares of the company’s stock, valued at $2,135,330.46. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Reeve B. Waud sold 50,000 shares of the business’s stock in a transaction dated Friday, June 9th. The shares were sold at an average price of $45.09, for a total value of $2,254,500.00. The disclosure for this sale can be found here. Insiders sold a total of 2,138,347 shares of company stock worth $105,486,669 over the last 90 days. Insiders own 11.10% of the company’s stock.
Large investors have recently added to or reduced their stakes in the stock. Public Employees Retirement System of Ohio raised its stake in Acadia Healthcare by 10.9% in the second quarter. Public Employees Retirement System of Ohio now owns 81,729 shares of the company’s stock valued at $4,036,000 after buying an additional 8,066 shares in the last quarter. Asymmetry Capital Management L.P. increased its position in shares of Acadia Healthcare by 594.0% in the second quarter. Asymmetry Capital Management L.P. now owns 82,694 shares of the company’s stock valued at $4,083,000 after buying an additional 70,779 shares during the last quarter. Ameritas Investment Partners Inc. acquired a new position in shares of Acadia Healthcare during the second quarter valued at approximately $1,129,000. Raymond James Financial Services Advisors Inc. increased its position in shares of Acadia Healthcare by 346.0% in the second quarter. Raymond James Financial Services Advisors Inc. now owns 34,757 shares of the company’s stock valued at $1,716,000 after buying an additional 26,964 shares during the last quarter. Finally, The Manufacturers Life Insurance Company boosted its stake in shares of Acadia Healthcare by 4,354.5% in the second quarter. The Manufacturers Life Insurance Company now owns 112,564 shares of the company’s stock valued at $5,558,000 after buying an additional 110,037 shares during the last quarter.
About Acadia Healthcare
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.
Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with MarketBeat.com's FREE daily email newsletter.